首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Xiao Chai Hu Tang for Peptic Ulcers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
【24h】

Xiao Chai Hu Tang for Peptic Ulcers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

机译:消化溃疡萧柴虎汤:随机对照试验的系统审查和荟萃分析

获取原文
           

摘要

A peptic ulcer (PU) is a digestive disorder most commonly found in clinical practice. An oriental herbal formula, Xiao Chai Hu Tang (XCHT), has been used to treat PU for an extended period in China. The effectiveness and safety of XCHT in treating peptic ulcers was evaluated using a systematic review of randomized controlled trials (RCTs). Studies were systematically retrieved from CNKI, Embase, Medline, PubMed, SinoMed, VIP, Wanfang, and Web of Science. The following information was extracted from the relevant RCTs: the clinical efficacy rate, recurrence rate, clinical efficacy of traditional Chinese medicine, and the adverse effects. 13 RCTs, including 1334 patients, were included in this review. The meta-analysis showed that treatment with XCHT was superior to conventional pharmacotherapy (CPT) in improving the clinical efficacy rate (RR: 1.20, 95% confidence intervals (CIs): 1.08–1.34, ), poor appetite (RR: 0.30, 95% CI: 0.15–0.61, ), abdominal distension (RR: 0.61, 95% CI: 0.39–0.96, ), vomiting (RR: 0.33, 95% CI: 0.19–0.55, ), and stomach pain (RR: 0.36, 95% CI: 0.19–0.68, ) and reducing adverse events (RR: 0.23, 95% CI: 0.07–0.69, ). XCHT considerably increased the total clinical efficacy rate (RR: 1.22, 95% CI: 1.15–1.30, ) as both monotherapy and adjunctive therapy. The recurrence rate (RR?=?0.29; 95% CI: 0.16–0.52, ) was remarkably decreased in the XCHT plus CPT group. The meta-analysis did not show a significant beneficial effect of XCHT compared with CPT in reducing the recurrence rate (RR?=?0.45; 95% CI: 0.07–3.10, ) and acid reflux (RR: 0.76, 95% CI: 0.47–1.23, ). Our findings show that XCHT can treat peptic ulcers as part of an alternative medicine approach.
机译:消化性溃疡(PU)是临床实践中最常见的消化系统疾病。东方草药配方,萧柴虎堂(XCHT)已被用来在中国延长治疗PU。使用对随机对照试验(RCT)的系统审查评估了XCHT治疗消化溃疡的有效性和安全性。从CNKI,EMBASE,MEDLINE,PUBMED,SINOMED,VIP,WANFANG和科学网上系统地检索研究。从相关的RCT中提取以下信息:临床疗效率,复发率,中医的临床疗效以及不良反应。 13次RCT,包括1334名患者,包括在本综述中。 Meta分析表明,用Xcht治疗优于常规药物疗法(CPT),提高临床疗效率(RR:1.20,95%置信区间(CIS):1.08-1.34,),食欲不佳(RR:0.30,95 %CI:0.15-0.61,),腹胀(RR:0.61,95%CI:0.39-0.96,),呕吐(RR:0.33,95%CI:0.19-0.55,)和胃痛(RR:0.36, 95%CI:0.19-0.68,)和减少不良事件(RR:0.23,95%CI:0.07-0.69)。 XCHT显着增加了总临床疗效率(RR:1.22,95%CI:1.15-1.30),作为单一疗法和辅助治疗。 XCHT加上CPT组中,复发率(RR?= 0.29; 95%CI:0.16-0.52,显着降低。与CPT降低复发率(RRα= 0.45; 95%CI:0.07-3.10,)和酸回流(RR:0.76,95%CI:0.47,相比,Meta分析与CPT相比,XCHT的显着有益效果-1.23,)。我们的研究结果表明,XCHT可以作为替代医学方法的一部分治疗消化性溃疡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号